[Video Profile] Interview with Terrance Gregg, President & CEO of DexCom

DexCom is developing a short term continuous glucose monitor for people with diabetes. The Seven System’s probe-like sensor is inserted by the user under the skin and is held in place by an adhesive. Once inserted, the Sensor begins continuously monitoring glucose. The Transmitter sends the glucose signal...

One Small Step for Muscular Dystrophy Treatment Requires Giant Leap for FDA

Dr. Eric Hoffman of the Children’s National Medical Center predicts that individualized molecular therapies will be medicine’s next big innovation, but only if the FDA revises its regulatory processes. In a recent edition of the New England Journal of Medicine, Dr. Hoffman shares the results of a...

[Video Profile] Interview with E. Kevin Hrusovsky, President & CEO of Caliper Life Sciences

Caliper Life Sciences combines microfluidics, liquid handling and laboratory automation to deliver research tools for drug discovery and development, and genomics and proteomics laboratories. The company uses direct, indirect distribution, and partnership channels to increase penetration of its products and...

Biosphere-DuPont Collaboration May Create Higher-Margin Microspheres

BioSphere Medical, which has an FDA approved method to treat symptomatic uterine fibroids using microsphere technology, has signed an agreement with DuPont Applied BioSciences to evaluate potential peripheral vascular and embolotherapy research, development, and manufacturing projects. The agreement...

Applied NeuroSolutions’ Test Predicts Disease Progression from Mild Cognitive Impairment to Alzheimer’s Disease

Mild cognitive impairment (MCI) affects many areas of cognition including language, attention, reasoning, and judgment. Many view MCI a transitional stage from the cognitive changes that accompany normal aging to the more serious complications brought on by Alzheimer’s disease. The Mayo Clinic...

AngioDynamics Technology Not Responsible for Lung Tumor Treatment Deaths

In February 2003, the FDA’s General and Plastic Surgery Devices Advisory Committee met and discussed thermal ablation of lung tumors. Concerns were raised about the safety and adverse event reporting associated with Radio Frequency ablation (RFA) of lung tumors. Last week, the FDA released a Public Health...

FDA Approves ATS’ AP360 Mechanical Heart Valve

The latest addition to ATS Medical’s suite of mechanical heart valve offerings, the AP360, has been approved for use in the U.S. The new design employs a supra-annular cuff that facilitates implantation and may appeal to a broader range of surgeons. Michael Dale, President and CEO of ATS commented,...

[Video] Interview with Charles Fleischman, Former President of Digene

In this interview, Charles Fleischman, former President, CFO, and COO of Digene, discusses building a company and taking a product from idea to market. Says Fleischman of raising capital, “If you continually under promise and over deliver you get a very good reputation with those same financing vehicles...